| Financial Year |
March 31 2023 |
| Monetary Funds |
4,828,741,847.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
414,366,740.71 |
| Accounts Receivable |
1,176,085,492.90 |
| Advances to Suppliers |
2,771,934,156.19 |
| Other Receivables |
18,828,134.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,067,925,375.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,795,471,864.67 |
| Other Current Assets |
441,936,370.68 |
| Total Current Assets |
14,580,095,109.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,136,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,072,040.11 |
| Fixed Assetes |
1,781,242,133.32 |
| Under-construction Projects |
422,826,704.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,084,443,192.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
50,063,992.79 |
| Other Non-Current Assets |
69,448,421.35 |
| Sub-Total of Non-Current Assets |
9,379,488,057.50 |
| Total Assets |
23,959,583,167.07 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,864,136,497.82 |
| Accounts Payable |
4,458,906,730.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,061,826.29 |
| Taxes Payable |
45,070,236.68 |
| Interest Payable |
-- |
| Dividend Payable |
1,367,900.00 |
| Other payables |
145,348,677.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,372,688.20 |
| Other Current Liabilities |
123,666,618.95 |
| Sub-Total of Current Liabilities |
12,129,885,738.63 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
545,870,663.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
622,078,274.68 |
| Total Liabilities |
12,751,964,013.31 |
| Paid-In Capital(Or Share Stock) |
1,703,779,257.00 |
| Capital Surplus |
4,417,341,044.77 |
| Surplus Reserve |
459,124,507.99 |
| LESS:Treasury Stock |
66,192,942.08 |
| Undistributed Profits |
4,546,013,178.63 |
| Minority Stockholder's Interest |
45,839,909.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,161,779,244.33 |
| Owner's Equity（Stockholder's Equity） |
11,207,619,153.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,959,583,167.07 |
